Eidelman Virant Capital’s Acacia Research ACTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$458K Sell
113,000
-50,000
-31% -$231K 0.34% 84
2022
Q2
$787K Buy
163,000
+30,000
+23% +$138K 0.57% 58
2022
Q1
$599K Hold
133,000
0.32% 82
2021
Q4
$685K Buy
133,000
+40,000
+43% +$216K 0.25% 88
2021
Q3
$644K Sell
93,000
-165,000
-64% -$1.01M 0.25% 92
2021
Q2
$1.74M Buy
+258,000
New +$1.54M 0.67% 44
2021
Q1
Sell
-40,000
Closed -$158K 175
2020
Q4
$158K Buy
40,000
+30,000
+300% +$108K 0.07% 153
2020
Q3
$36K Sell
10,000
-10,000
-50% -$38.9K 0.02% 147
2020
Q2
$82K Buy
+20,000
New +$58K 0.06% 110

Other funds holding ACTG

Eidelman Virant Capital's ACTG Position: Q3 2022 in Review

Eidelman Virant Capital reduced its Acacia Research (ACTG) stake by 31% in Q3 2022, selling an estimated $231K and leaving 113,000 shares worth $458K. The position accounts for 0.34% of the portfolio, ranked #84.

Eidelman Virant Capital first reported a position in ACTG in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.74M in Q2 2021. 77 funds tracked by Wall St. Rank hold ACTG as of Q3 2022.

  • Eidelman Virant Capital held 113,000 shares of Acacia Research worth $458K as of Q3 2022.
  • Eidelman Virant Capital sold 50,000 Acacia Research shares in Q3 2022, an estimated $231K.
  • Acacia Research made up 0.34% of Eidelman Virant Capital's portfolio in Q3 2022, its #84 holding.
  • Eidelman Virant Capital first reported a position in Acacia Research in Q2 2020 and has held it in 9 quarters since.
  • Eidelman Virant Capital's Acacia Research position peaked at $1.74M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Acacia Research as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.